The effect of perchlorate medication on point-of-care testing

Clin Lab. 2012;58(9-10):1067-70.

Abstract

Background: To create awareness for mismeasurements of ion-selective electrodes caused by patients' medications and to prevent severe consequences in an intensive care therapy.

Case presentation: A 73-year-old woman presented with severe carbimazol-induced toxic epidermal necrolysis. After replacement of carbimazol by sodiumperchlorate, we detected a huge discrepancy in the measurement of ionised calcium by two different Point-of-Care (POCT) systems. While Siemens Rapidlab 865 showed a severe hypocalcemia at all times, the Radiometer 600 system first presented a severe hypercalcemia and, in the course of the following days, also a hypocalcemia but with significantly (p < 10 to the -45) higher values than the Rapidlab system. Furthermore, the POCT systems detected a pseudohypocalcemia at times where we think there was a normo- or even hypercalcemia which led to incorrect therapy with excessive substitution of ionised calcium.

Conclusions: The substance sodiumperchlorate, which is well established in Europe for hyperthyreosis therapy, caused malfunctions of analyses of ionised calcium by POCT systems.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antithyroid Agents / chemistry*
  • Artifacts
  • Blood Chemical Analysis*
  • Calcium / blood
  • Calcium / chemistry*
  • Diagnostic Errors / prevention & control
  • False Positive Reactions
  • Female
  • Humans
  • Hypocalcemia / chemically induced
  • Hypocalcemia / diagnosis
  • Perchlorates / chemistry*
  • Point-of-Care Systems*
  • Sodium Compounds / chemistry*

Substances

  • Antithyroid Agents
  • Perchlorates
  • Sodium Compounds
  • sodium perchlorate
  • Calcium